Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
  • Rating
    3
  • Minimum Investment
    ₹1000
  • NAV (Net Asset Value)
    ₹N/A
  • AUM (Fund size)
    ₹1103 Cr
  • Created on
    3 July 2019
Fund Ranking
#13
/ 17 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    17.9%
  • 1 Year
    14.9%
  • 3 Year (CAGR)
    18.8%
  • All Time (CAGR)
    19.0%
Category Return
  • 6 Month
    18.4%
  • 1 Year
    13.5%
  • 3 Year (CAGR)
    20.1%
  • All Time (CAGR)
    16.9%
Asset Allocation
  • Equity
    96.4%
  • Other
    3.6%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    6.85%
  • Aurobindo Pharma
    4.53%
  • Cipla
    5.16%
  • Dr. Reddy's Laboratories
    1.04%
  • Ipca Laboratories
    2.71%
Fund Information
  • Expense Ratio
    2.29%
  • Exit Load
    Exit load of 1% if redeemed within 30 days.
  • Lock-In Period
    No Lock-In

Managed By

Dhaval Shah
June 2019 - Present
Dhaval Joshi
Nov 2022 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.82
  • Standard Deviation
    15.55
  • Alpha
    -1.06
  • Beta
    0.91